Functional Information from GO Data
Chain | GOid | namespace | contents |
A | 0005576 | cellular_component | extracellular region |
A | 0030550 | molecular_function | acetylcholine receptor inhibitor activity |
A | 0035821 | biological_process | modulation of process of another organism |
A | 0090729 | molecular_function | toxin activity |
A | 0099106 | molecular_function | ion channel regulator activity |
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 7 |
Details | BINDING SITE FOR RESIDUE SO4 A 63 |
Chain | Residue |
A | ARG1 |
A | ASN5 |
A | LYS15 |
A | GLU56 |
A | HOH103 |
A | HOH112 |
A | HOH127 |
site_id | CMR |
Number of Residues | 13 |
Details | RESIDUES, INCLUDING FOUR CYSTINE LINKAGES, WHICH AID IN MAINTAINING THE UNIQUE TOXIN FOLD CONFORMATION |
Chain | Residue |
A | CYS3 |
A | PHE4 |
A | CYS17 |
A | CYS24 |
A | TYR25 |
A | GLY40 |
A | CYS41 |
A | GLY42 |
A | CYS43 |
A | CYS54 |
A | CYS55 |
A | CYS60 |
A | ASN61 |
site_id | FNR |
Number of Residues | 4 |
Details | RESIDUES IN THE REACTIVE SITE SHOWN CHEMICALLY TO BIND DIRECTLY TO RECEPTOR |
Chain | Residue |
A | LYS27 |
A | TRP29 |
A | ARG33 |
A | LYS47 |
site_id | RCT |
Number of Residues | 20 |
Details | THE SERIES INVARIANT RESIDUES OF THE REACTIVE SITE. FIVE OF THESE RESIDUES (PHE 32, ILE 36, GLU 38, ILE 50, LEU 52) ARE TYPE-CONSERVED THROUGHOUT THE SERIES. THE ENUMERATION IS FOR A 62-RESIDUE TOXIN |
Chain | Residue |
A | TYR25 |
A | GLY40 |
A | CYS41 |
A | GLY42 |
A | CYS43 |
A | PRO44 |
A | VAL46 |
A | LYS47 |
A | GLY49 |
A | ILE50 |
A | LEU52 |
A | LYS27 |
A | CYS54 |
A | TRP29 |
A | ASP31 |
A | PHE32 |
A | ARG33 |
A | GLY34 |
A | ILE36 |
A | GLU38 |
Functional Information from PROSITE/UniProt
site_id | PS00272 |
Number of Residues | 19 |
Details | SNAKE_TOXIN Snake toxins signature. GCg..CPtvkpgikls.CCesE |
Chain | Residue | Details |
A | GLY40-GLU58 | |
Functional Information from SwissProt/UniProt
site_id | SWS_FT_FI1 |
Number of Residues | 14 |
Details | Region: {"description":"Loop I","evidences":[{"source":"PubMed","id":"7721859","evidenceCode":"ECO:0000305"}]} |
site_id | SWS_FT_FI2 |
Number of Residues | 5 |
Details | Region: {"description":"Stretch between loop I and loop II","evidences":[{"source":"PubMed","id":"7721859","evidenceCode":"ECO:0000305"}]} |
site_id | SWS_FT_FI3 |
Number of Residues | 17 |
Details | Region: {"description":"Loop II","evidences":[{"source":"PubMed","id":"7721859","evidenceCode":"ECO:0000305"}]} |
site_id | SWS_FT_FI4 |
Number of Residues | 11 |
Details | Region: {"description":"Loop III","evidences":[{"source":"PubMed","id":"7721859","evidenceCode":"ECO:0000305"}]} |
site_id | SWS_FT_FI5 |
Number of Residues | 3 |
Details | Site: {"description":"Moderately important residue for binding to acetylcholine receptor","evidences":[{"source":"PubMed","id":"7721859","evidenceCode":"ECO:0000269"}]} |
site_id | SWS_FT_FI6 |
Number of Residues | 4 |
Details | Site: {"description":"Very important residue for binding to acetylcholine receptor","evidences":[{"source":"PubMed","id":"7721859","evidenceCode":"ECO:0000269"}]} |
site_id | SWS_FT_FI7 |
Number of Residues | 3 |
Details | Site: {"description":"Key residue for binding to acetylcholine receptor","evidences":[{"source":"PubMed","id":"7721859","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"8419369","evidenceCode":"ECO:0000269"}]} |
site_id | SWS_FT_FI8 |
Number of Residues | 1 |
Details | Site: {"description":"Key residue for binding to acetylcholine receptor","evidences":[{"source":"PubMed","id":"8419369","evidenceCode":"ECO:0000269"}]} |
site_id | SWS_FT_FI9 |
Number of Residues | 2 |
Details | Site: {"description":"Very important residue for binding to acetylcholine receptor","evidences":[{"source":"PubMed","id":"8419369","evidenceCode":"ECO:0000269"}]} |
site_id | SWS_FT_FI10 |
Number of Residues | 2 |
Details | Site: {"description":"Moderately important residue for binding to acetylcholine receptor","evidences":[{"source":"PubMed","id":"8419369","evidenceCode":"ECO:0000269"}]} |